Lasa Supergenerics Limited

NSEI:LASA Stock Report

Market Cap: ₹1.2b

Lasa Supergenerics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Lasa Supergenerics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth17.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Jun 05
We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Mar 13
Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

Dec 28
Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Jul 05
We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt

Mar 28
Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt

Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25

Sep 02
Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25

Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?

Aug 13
Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?

A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)

Jun 21
A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)

Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?

Dec 06
Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lasa Supergenerics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:LASA - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20241,043-2172121N/A
12/31/20231,168-214N/AN/AN/A
9/30/20231,219-249-54-50N/A
6/30/20231,312-315N/AN/AN/A
3/31/20231,296-386-173-173N/A
12/31/20221,455-113N/AN/AN/A
9/30/20221,295-1114962N/A
6/30/20221,299-183N/AN/AN/A
3/31/20221,371-539292N/A
12/31/20211,250-139N/AN/AN/A
9/30/20211,633-262692N/A
6/30/20211,838182N/AN/AN/A
3/31/20212,024228347413N/A
12/31/20202,118216N/AN/AN/A
9/30/20201,972176272264N/A
6/30/20201,829101N/AN/AN/A
3/31/20201,67336130136N/A
12/31/20191,607-8N/AN/AN/A
9/30/20191,753-86N/AN/AN/A
6/30/20191,756-101N/AN/AN/A
3/31/20191,696-120293407N/A
12/31/20181,869-167N/AN/AN/A
9/30/20181,940-83N/AN/AN/A
6/30/20182,17555N/AN/AN/A
3/31/20182,435123-64404N/A
6/30/20172,184-10N/AN/AN/A
3/31/20172,18224N/A-30N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if LASA's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if LASA's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if LASA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if LASA's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if LASA's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if LASA's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.